atorvastatin has been researched along with kainic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JK; Singh, AK; Singh, I; Won, JS | 1 |
| Guo, FL; Li, C; Liu, Z; Lu, CB; Vreugdenhil, M; Wang, J; Wang, XF; Wang, Y; Zhao, J | 1 |
| Bergin, DH; Johne, M; Klein, P; Löscher, W; Schidlitzki, A; Twele, F; Welzel, L | 1 |
3 other study(ies) available for atorvastatin and kainic acid
| Article | Year |
|---|---|
Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death.
Topics: Animals; Atorvastatin; Cell Death; Disease Models, Animal; Dose-Response Relationship, Drug; Ectodysplasins; Heptanoic Acids; Hippocampus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Situ Nick-End Labeling; Inflammation; Interleukin-1beta; Kainic Acid; Male; Nitric Oxide Synthase Type II; Pyrroles; Rats; Rats, Sprague-Dawley; Seizures; Tumor Necrosis Factor-alpha | 2008 |
Atorvastatin enhances kainate-induced gamma oscillations in rat hippocampal slices.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; CA3 Region, Hippocampal; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Gamma Rhythm; Inhibitory Postsynaptic Potentials; Interneurons; Kainic Acid; Male; Protein Kinase Inhibitors; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2016 |
Systematic evaluation of rationally chosen multitargeted drug combinations: a combination of low doses of levetiracetam, atorvastatin and ceftriaxone exerts antiepileptogenic effects in a mouse model of acquired epilepsy.
Topics: Animals; Anticonvulsants; Atorvastatin; Ceftriaxone; Drug Delivery Systems; Drug Evaluation, Preclinical; Drug Therapy, Combination; Electroencephalography; Epilepsy; Kainic Acid; Levetiracetam; Male; Mice; Treatment Outcome | 2021 |